|
OCX Oncocyte Corp 1642380 |
| Balance Sheet |
|
Current Assets
|
4,793,000 |
|
Assets
|
70,216,000 |
|
Current Liabilities
|
9,090,000 |
|
Liabilities
|
60,505,000 |
|
Equity
|
9,711,000 |
|
Shares Out
|
13,368,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-15,359,000 |
|
Investing Cash Flow
|
-302,000 |
| Market Analysis |
Market Cap
|
41,281,558 |
|
Price
|
2.08 |
|
BVPS
|
0.73 |
|
PB
|
2.89 |
|
EPS
|
-4.26 |
|
PS
|
89.74 |
|
FCF
|
-15,661,000 |
|
| Earnings |
|
| Apr |
May |
Jun |
| 4/12 |
|
5/15 |
-1.13 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view OCX documents filed with the SEC.
OCX Filings
Clear
